Am I on the right track as to how Trump intends to win the election?
I think I can figure out the operation vaccine warped Speed?
He will pass all the vaccines and you will need to have 10 different vaccines?
I am reading the J&J vaccine plans and they are saying you will probably need more than one vaccine maybe 10? All will pass by September so he can try to win the election. That is his master plan.
J&J said they could change their mind but right now they are not going to test the people that have the vaccine with the actual Covid to see if their vaccine actually works.
So, the drug companies will not even have to test the vaccines to see if they really work?
Is this the mighty vaccine plan and Trump is running?
Plus they are saying they will not make any money off the vaccines but you cannot sue vaccines makers according to US laws even if they make you sick or even worst.3 AnswersLaw & Ethics3 months ago
- 3 AnswersRap and Hip-Hop8 months ago
- 13 AnswersPolitics3 years ago
- 5 AnswersGlobal Warming3 years ago
“Chickens raised with arsenic-based drugs resulted in chicken meat that had higher levels of inorganic arsenic, a known carcinogen,” said Keeve Nachman, PhD, Assistant Professor and Director of Food Production and Public Health Program at The Johns Hopkins Center for a Livable Future and lead author of a 2013 study on arsenic in poultry. “It’s critical the FDA ensure its recommendations are issued in a timely manner, and are driven solely by science and a commitment to protecting the public’s health.”
“These documents paint a troubling picture for the U.S food supply and expose the true extent of Pfizer’s lobbying and public relations efforts. Since the FDA agreed to allow Pfizer to voluntarily stop using roxarsone in the U.S. and did not withdraw approval, it allows Pfizer to continue manufacturing and selling the drug overseas, putting other populations at risk,” added Hauter.2 AnswersPolitics6 years ago
Anyone know the name of this Movie?
Filmed at a shopping Mall in Canada with a couple of Mall workers betting who will last the longest inside the Mall without any outside sunshine or fresh air?
One actor sneaked outside inside a trashcan on wheels to get some sun light and fresh air.
I can not remember the name of the Movie?1 AnswerMovies7 years ago
Called my MD had a 101.4 fever. sick. blacked out. fell down unconscious. body all bruised.
MD Never called me back.
Called my MD emergency cell phone number. Never called me back.
Went to EM at hospital.
Was examined by the Nurse.
Sat down waited from 8:00 pm to 1:00 am
Nurse took roll call at 1:00 and said they are busy.
No Doctors anywhere to be seen.
Told them I would go home and take a nap and come back since I was very sick
emergency room waiting room was freezing cold and I was shivering and flu like sick.
Emergency Room furniture was dirty filthy and rug was disgusting dirty color.
Full of people waiting for Doctor.
Noticed About 4 patients had big toe injury wearing flip flops.
Went home took a nap. Fever kept going up and down.
Finally I felt not as sick after 3 days.
I was better, but never found out what was wrong.
WHY can't I see a Doctor? I got insurance.4 AnswersOther - Diseases8 years ago
The Pigs Contracted H1N1 virus from school children.
Had this occurred in China, Hong Kong or Vietnam the farm animals would have been quarantined and slaughtered to prevent the animals from mutating into new Virus Strains.
In Asia they killed millions of chickens to prevent the avian flu from spreading.
Sorry to the 4H club and your pet pigs but the H1N1 swine flu virus might mutate.
IMHO, The infected farm animals should be quarantined and slaughtered.
My Question: In the USA should we have the same policy?3 AnswersInfectious Diseases1 decade ago
JAMA news today Inexpensive protection for HIV patients.
I have long suggested in my humble opinion trying Selenium for Chemotherapy and Radiation patients.
"Advances in antiretroviral therapy (ART) have given HIV patients a longer life expectancy, according to background information in the article. However, strict adherence to the therapy is required to keep HIV viral counts low, and there is a risk of toxic effects and metabolic dysfunction.
“Given the challenges of using conventional pharmacotherapy to achieve and maintain virologic suppression in HIV-spectrum disease, our results support the use of selenium as a simple, inexpensive and safe adjunct therapy,” the authors conclude in an article in the January 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. "1 AnswerCancer1 decade ago
New adjunct chemo cures twice as many people with cancer and has been shown to increase tolerance to chemo so everybody can take their medicine.
Yet, I have been attacked for posting these promising medical studies.
The medicine is real and the results are real too!
Any idea why medical professions have a negative sentiment to a new cure?
Novelos has announced positive results of a phase I/II trial of NOV-002, for the treatment of non-small cell lung cancer. The drug is currently approved in Russia, where it is marketed as Glutomix. Intent-to-treat analysis indicated that 69% (11/16) of subjects receiving intravenous (IV) and subcutaneous (SC) NOV-002 in combination with chemotherapy achieved objective (complete or partial) tumor response, vs. 33% (5/15) receiving chemotherapy alone (p=0.044). Subjects receiving NOV-002 via IV and intramuscular (IM) injection plus chemotherapy experienced a non-significant 46% (6/13) objective response rate. The drug also produced improved tolerance of chemotherapy in both dosing groups, with 100% of the IV/SC and 85% of the IV/IM subjects completing 4 cycles of chemotherapy, vs. 50% of subjects receiving chemotherapy alone (p=0.004). This randomized, controlled study enrolled 44 patients, who received one of two regimens of NOV-002 (IV/SC or IV/IM) plus chemotherapy or chemotherapy alone for 6 months. The company announced plans to initiate phase II/III trials of the drug in 2006, based on these results.3 AnswersCancer1 decade ago
Novelos Therapeutics Enrolls 1st Patient in Pivotal Phase 3 Lung Cancer Trial
Monday November 6, 8:30 am ET
Full Enrollment Expected in 1Q 2008
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT - News), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the first patient has been enrolled in the pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) for its lead product NOV-002 in combination with first-line chemotherapy. Thomas Lynch, M.D. and Panos Fidias, M.D. from Massachusetts General Hospital (MGH) are the trial co-Chairs. Dr. Lynch is Director of MGH's Center for Thoracic Cancers and Dr. Fidias is Clinical Director for the Center.
This randomized, open-label, international Phase 3 trial is being conducted under a Special Protocol Assessment (SPA) and will study 840 patients with Stage IIIb/IV NSCLC.1 AnswerCancer1 decade ago
NOV-002, the lead compound acts as a chemoprotectant and an immunomodulator. It is marketed in Russia by PharmaBAM under the trade name Glutoxim®, and has been administered to over 5,000 patients, demonstrating clinical efficacy and excellent safety. The U.S.-based Phase 1/2 clinical trial of NOV-002 for non-small cell lung cancer (NSCLC) has been completed, with positive results. During an End-of-Phase 2 meeting, the FDA agreed that advancing NOV-002 into a pivotal Phase 3 trial in advanced NSCLC, in combination with first-line chemotherapy, is warranted. In May 2006, Novelos finalized a Special Protocol Assessment (SPA) with the FDA for a single pivotal trial, obtained Fast Track designation in August 2006, and this Phase 3 trial commenced in November 2006. NOV-002 is also in Phase 2 development for chemotherapy-resistant ovarian cancer and early-stage breast cancer, and is in addition being developed for acute radiation injury.2 AnswersCancer1 decade ago
Lance Armstrong: Patience running thin with D.C.
POSTED: 5:13 p.m. EST, January 10, 2007
Lance Armstrong, one of cycling's all-time greats and possibly the world's best known cancer survivor, founded the Lance Armstrong Foundation with the goal of inspiring and empowering people with cancer. He now campaigns for more government funds for cancer research and treatment.
AUSTIN, Texas (CNN) -- I'm not known for my patience. Patience is a polite quality and often appropriate, but it rarely gets things done. Impatience, however, is the hunger for results and intolerance for excuses and delays. Impatience got me over countless mountain passes, across the finish line in New York City and through four rounds of ruthless chemotherapy 10 years ago.
Yet this election season I patiently waited to hear a candidate for office explain to constituents what he or she planned to do about one of the leading threats to the health and well-being of all Americans -- cancer. My patience was greeted with silence.
Cancer will impact one in two men and one in three women in their lifetime. It is devastating and it is pervasive. In fact, every year 1.3 million Americans are diagnosed with cancer. (Visit a CNN special, "Saving Your Life" )
Thankfully, our country has made tremendous progress in this fight and produced remarkable advances in the way we prevent, diagnose and treat cancer. Today, in many cases, we can humbly say that cancer is no longer a death sentence. The medical advances achieved by our nation's best doctors and researchers have given us reasons to hope.
But in spite of this vast body of knowledge, 1,500 people will die from cancer today and tomorrow and the day after that, often because the care they needed to prevent cancer or survive it was not available to them. (Watch cancer survivors describe their ordeal )
However, our nation's second-leading killer did not make the list of issues that our candidates used to get people to the polls last November. Anyone with a television or access to a newspaper can list the ballot box issues that occupied our candidates' attention -- they range from bickering to very real concerns and challenges.
The political ads didn't tell voters that earlier in the year funding for cancer research was cut for the first time in 30 years. Nor did they explain that a lack of funding slows the pace of scientific discovery and the development of treatments. Our candidates did not mention the decrease in funding for programs that provide information and screening to people who need these services. I think this is unwise, but it is what our government has done this past year. I waited patiently for an explanation, some clarification or justification. Ten million cancer survivors deserve an answer. We didn't get one.
It is true that state and federal budgets are constrained by many important responsibilities. But cancer doesn't care about that.
It is time to hold our leaders accountable. It remains to be seen if the change in power on Capitol Hill will affect the fight against cancer. In two years we will elect a new president. We cannot predict the actions of any of our elected officials, but we can say for sure that when it comes to cancer their silence is unacceptable.
Patient people may accept the status quo, but the status quo isn't working for us. Instead, we need to stubbornly hold our leaders accountable and we need the courage to ask tough questions of our elected officials. Few issues facing our government are more personal or more critical than the health of our citizens. What are we going to do to effectively fight cancer? Millions of Americans with cancer are asking.3 AnswersCancer1 decade ago
NOV 002 is now Waiting for FDA Approval.
Novelos Therapeutics Obtains FDA Fast Track Designation for NOV-002 Lung Cancer Treatment
Monday August 7, 8:30 am ET
NEWTON, Mass.--(BUSINESS WIRE)--Aug. 7, 2006--Novelos Therapeutics, Inc. (OTCBB: NVLT - News), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the Food and Drug Administration (FDA) has granted Fast Track designation to NOV-002 for use in combination with first-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC). The FDA's Fast Track program is designed to facilitate the development and accelerate the review process for new drugs that have the potential to address a serious and unmet medical need for conditions such as advanced NSCLC.2 AnswersCancer1 decade ago
Has been approved as an adjunct to conventional chemotherapy in Russia.
BUT, is still waiting for FDA approval in the USA
Manufactured by Novelos Therapeutics (NVLT.ob)
Cures 80% more cancer patients than conventional Chemo.
In Russian studies and one US study NOV-002 allowed cancer patients to become 100% tolerant to conventional chemo.
How come NOV-002 is not FDA approved?
Could have saved so many lives!4 AnswersCancer1 decade ago
Anyone know you can buy a natural gas car and fuel your car at home?
Never need to drive to the gas station ever again.
Save money fuel at home using PHILL?
Did anyone see the Honda GX PDF.file on the Clean Site?
The same car on the Honda Site?2 AnswersOther - Cars & Transportation1 decade ago